Delivery Order SPE2DB24D9644-SPE2DB25FLGNQ

Award Date 10/30/24
Potential Completion Date 11/21/24
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,717.52 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,566,419,389 units of the NEXPLANON 68 MG IMPLANTS pharmaceutical product. This delivery order was placed under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with DLA, valued at $499,999,999 and valid through November 2026. The IDC allows DLA...
The Defense Logistics Agency (DLA) awarded a $3,573.45 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Nexplanon 68 mg implants. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $8,576.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Nexplanon 68 mg implants to meet the recurring medical supply needs of military health facilities. This Delivery Order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA...
The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $8,331.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a specialized pharmaceutical product, with a period of performance through March 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
The Defense Logistics Agency (DLA) awarded a $4,288.14 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,384,225 units of NEXPLANON 68 MG IMPLANTS, a specialized pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group Inc. under the SPE2DB program, valued at $499,999,999 and valid...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $7,146.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for the provision of 4,566,383,795 units of the NEXPLANON 68 MG IMPLANTS contraceptive device. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $14,759.04 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the procurement of 4,558,363,037 units of Nexplanon 68 mg implants. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which enables the agency to issue firm fixed-price orders for a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $8,576.28 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, a pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which provides a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,837.40, is for the delivery of 4,562,331,276 Nexplanon 68 mg implants. This delivery order is issued under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which allows the DLA to order a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,144.07, is for the delivery of Nexplanon 68 mg implants. This order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, which allows the agency to issue delivery orders for a...
  • SPE2DB24D9644
    Indefinite Delivery Contract
  • SPE2DB24D9644-SPE2DB25FLGNQ
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $50,063.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,465,286 units of the NEXPLANON 68 MG IMPLANTS product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which covers a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 1/29/25, 9:20 AM